Unbridled Excellence #3:
For the third episode of this webinar series, we'll get the chance to hear from not one but two DHC Senior Consultants, Joshua Beckett and Alicja Fiedorowicz MSc,, on the topic of Phase Appropriate Analytics to Support Cell and Gene Therapy Development.
Wednesday, October 25, 2023
9 am Pacific Time
Presenters will discuss several considerations for implementation of a phase-appropriate analytical strategy to support the development of cell and gene therapies. The concept of phase-appropriateness will be introduced, along with a discussion of how this concept may influence the strategy for release and characterization testing as a product proceeds through development. Presenters will also discuss phase-appropriateness in the context of assay qualification, validation, and potency assay strategy.
Register for Phase Appropriate Analytics to Support Cell and Gene Therapy Development here.